Sungmi Park

Gyeonggi-do, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Cell-penetrating asymmetric siRNA targeting MyD88 suppresses inflammasome-driven ocular degeneration and angiogenesis.

Cell-penetrating asymmetric siRNA targeting MyD88 suppresses inflammasome-driven ocular degeneration and angiogenesis.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 09, 2025

In vivo efficacy of NRL knockdown with cell-penetrating siRNA in retinal degeneration.

In vivo efficacy of NRL knockdown with cell-penetrating siRNA in retinal degeneration.

Journal: Scientific reports

Published: January 21, 2025

PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration.

PDK4-mediated metabolic reprogramming is a potential therapeutic target for neovascular age-related macular degeneration.

Journal: Cell death & disease

Published: April 19, 2024

Identification of New Non-BBB Permeable Tryptophan Hydroxylase Inhibitors for Treating Obesity and Fatty Liver Disease.

Identification of New Non-BBB Permeable Tryptophan Hydroxylase Inhibitors for Treating Obesity and Fatty Liver Disease.

Journal: Molecules (Basel, Switzerland)

Published: March 31, 2022

Drug evaluation based on phosphomimetic PDHA1 reveals the complexity of activity-related cell death in A549 non-small cell lung cancer cells.

Drug evaluation based on phosphomimetic PDHA1 reveals the complexity of activity-related cell death in A549 non-small cell lung cancer cells.

Journal: BMB reports

Published: July 26, 2021

Pyruvate dehydrogenase kinase 1 and 2 deficiency reduces high-fat diet-induced hypertrophic obesity and inhibits the differentiation of preadipocytes into mature adipocytes.

Pyruvate dehydrogenase kinase 1 and 2 deficiency reduces high-fat diet-induced hypertrophic obesity and inhibits the differentiation of preadipocytes into mature adipocytes.

Journal: Experimental & molecular medicine

Published: November 18, 2020

Fursultiamine Alleviates Choroidal Neovascularization by Suppressing Inflammation and Metabolic Reprogramming.

Fursultiamine Alleviates Choroidal Neovascularization by Suppressing Inflammation and Metabolic Reprogramming.

Journal: Investigative ophthalmology & visual science

Published: October 27, 2020

Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors.

Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors.

Journal: Journal of medicinal chemistry

Published: August 31, 2019

Correction to Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.

Correction to Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.

Journal: Journal of medicinal chemistry

Published: February 28, 2019

Therapeutic effect of dichloroacetate against atherosclerosis via hepatic FGF21 induction mediated by acute AMPK activation.

Therapeutic effect of dichloroacetate against atherosclerosis via hepatic FGF21 induction mediated by acute AMPK activation.

Journal: Experimental & molecular medicine

Published: February 18, 2019

Progression of Multifaceted Immune Cells in Atherosclerotic Development.

Progression of Multifaceted Immune Cells in Atherosclerotic Development.

Journal: Journal of lipid and atherosclerosis

Published: February 02, 2019

Pyruvate Dehydrogenase Kinase Is a Metabolic Checkpoint for Polarization of Macrophages to the M1 Phenotype.

Pyruvate Dehydrogenase Kinase Is a Metabolic Checkpoint for Polarization of Macrophages to the M1 Phenotype.

Journal: Frontiers in immunology

Published: January 19, 2019

Showing 1-12 of 25

Last Updated: 09/26/2026